Skip to search formSkip to main contentSkip to account menu

therasphere

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
HCC Radioembolization with Yttrium-90 Glass Microspheres (TheraSphere)
Intraarterial radioembolization (RE) using microspheres labelled with the high-energy beta-emitter yttrium-90 (90Y) is an… 
2018
2018
Particle Characterization of Non-Radioactive Preparations of a Beta-Emitting Liquid Brachytherapy Agent for Solid Tumor Treatment
Overall Hypothesis and Goals Brachytherapy is a type of cancer radiotherapy in which radioactive implants are inserted directly… 
2017
2017
Understanding the role of BHLHE 40 and its regulation by the androgen receptor in prostate cancer
not available for publication Towards single exosome RNA sequencing for phenotyping ovarian cancer Randy Carney, Mac Colquhoun… 
2017
2017
Lung Shunt Estimate in Yttrium-90 Microsphere Therapy
This study was to evaluate lung shunting from Tc-99m MAA (Macroaggregated Albumin) and Y-90 imaging, and its effect on treatment… 
2015
2015
Phase 3 clinical Trial Evaluating 90y glass microspheres in patients with metastatic colorectal carcinoma of the liver who have failed first-line chemotherapy.
474 Background: Colorectal cancer (CRC) is the third most common cancer in the US. Half of pts diagnosed with CRC develop liver… 
2015
2015
A phase III clinical trial of intra-arterial yttrium-90 glass microspheres in the treatment of patients with unresectable hepatocellular carcinoma.
477 Background: Primary liver cancer is the fifth most commonly diagnosed cancer in men and eight most common in women. Currently… 
2014
2014
Rationale of Radioembolization in Intermediate and Advanced Stage Hepatocellular Cancer
Transarterial Chemoembolization (TACE) has been recommended to choice of treatment for intermediate stage patients in several… 
2010
2010
Actitud a seguir ante la detección de una lesión focal inferior o igual a 2 cm de tamaño en un paciente con cirrosis hepática
ANTECEDENTES: El diagnostico precoz del carcinoma hepatocelular es la unica opcion para poder aplicar tratamientos radicales… 
2008
2008
A randomized, controlled study of TACE versus 90Yttrium microspheres for treatment of unresectable HCC: Interim results
15609 Hepatic arterial 90Yttrium microspheres has been associated with prolonged survival and low toxicity in the treatment of… 
2005
2005
90 Y Microsphere (TheraSphere) Treatment for Unresectable Colorectal Cancer Metastases of the Liver: Response to Treatment at Targeted Doses of 135-150 Gy as Measured by ( 18 F)Fluorodeoxyglucose…
was correlated with response on [ 18 F]fluorodeoxyglucose (FDG) positron emission tomography (PET). Survival from first treatment… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)